Inflammation & Longevity Blood Panel

Comprehensive inflammation and longevity blood panel measuring C-reactive protein, ESR, oxidative stress markers, and metabolic health indicators, reviewed by a physician to guide anti-aging and preventive health strategies.

Chronic low-grade inflammation — sometimes termed 'inflammaging' — is recognised as one of the key biological drivers of accelerated aging, metabolic dysfunction, and the development of major chronic diseases including cardiovascular disease, type 2 diabetes, neurodegenerative conditions, and some cancers. The Clifford Clinic's inflammation and longevity blood panel is designed to quantify the level of systemic inflammation and identify addressable drivers, providing a biological baseline and allowing the patient's response to lifestyle or treatment interventions to be tracked objectively. The panel typically includes high-sensitivity C-reactive protein (hsCRP), a sensitive marker of systemic inflammation that predicts cardiovascular risk independently of cholesterol levels; erythrocyte sedimentation rate (ESR), a broader marker of inflammatory activity; ferritin, which is elevated in inflammatory states; and a metabolic component covering fasting glucose, insulin, and lipid fractions to reveal insulin resistance and dyslipidaemia that both drive and are driven by inflammation. Depending on the clinical picture, the physician may extend the panel to include homocysteine (a marker of vascular risk), interleukin-6 or TNF-alpha (direct inflammatory cytokines), or thyroid function tests where thyroid-driven inflammation is suspected. Results are reviewed in a consultation with one of the clinic's longevity physicians, who contextualises the findings against the patient's age, lifestyle, weight, and symptoms. Where inflammation is elevated, the discussion covers the most likely sources — dietary patterns, sleep quality, exercise load, microbiome composition, chronic infection, or environmental exposures — and the interventions most likely to reduce it. These may include HBOT, which has demonstrated anti-inflammatory mechanisms in peer-reviewed studies, dietary modification supported by gut microbiome data, or targeted supplementation. The panel is offered as a standalone service or integrated into the clinic's comprehensive longevity assessment alongside genetic testing, hormone profiling, and body composition analysis.